| Date | Title |
| 2024-11-05 | Infliximab: The First Monoclonal Antibody in Inflammatory Disease |
| 2024-10-29 | Week 5, October 2024: Anti-Amyloid Monoclonal Antibodies |
| 2024-10-01 | What is Hybridoma Technology? |
| 2024-09-26 | What is Antibody Drug Development? |
| 2024-09-24 | Week 4, September 2024: Anti-TIGIT Therapies |
| 2024-09-19 | What are Antibody Therapeutics? |
| 2024-09-12 | What are Monoclonal Antibodies? |
| 2024-09-10 | Antibodies: Applications as Tools |
| 2024-09-03 | Week 1, September 2024: Prurigo Nodularis & FDA Approvals |
| 2024-08-13 | Week 2, August 2024: Hepatitis B Virus (HBV) |
| 2024-07-09 | Week 2, July 2024: An Update on Alzheimer’s Antibody Drugs |
| 2024-05-31 | Antibody-Antibiotic Conjugates (AACs) in the Fight Against Bacterial Infections |
| 2024-05-30 | May 2024: The Ozempic Craze: In the Perspective of Antibody Drugs |
| 2024-05-21 | Week 3, May 2024: A Continued Look at the Progress of COVID Therapies |
| 2024-05-16 | Muronomab: The First Approved Monoclonal Antibody |
必要な情報が見つからない場合は、お気軽にご連絡ください！
ScientistとScience Exchangeとのご利用可能です。
お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。
